291 related articles for article (PubMed ID: 28705120)
1. QSAR, docking, ADMET, and system pharmacology studies on tormentic acid derivatives for anticancer activity.
Alam S; Khan F
J Biomol Struct Dyn; 2018 Jul; 36(9):2373-2390. PubMed ID: 28705120
[TBL] [Abstract][Full Text] [Related]
2. Detection of Natural Inhibitors against Human Liver Cancer Cell Lines through QSAR, Molecular Docking and ADMET Studies.
Alam S; Nasreen S; Ahmad A; Darokar MP; Khan F
Curr Top Med Chem; 2021; 21(8):686-695. PubMed ID: 33280598
[TBL] [Abstract][Full Text] [Related]
3. 3D-QSAR and docking studies on ursolic acid derivatives for anticancer activity based on bladder cell line T24 targeting NF-kB pathway inhibition.
Yadav D; Nath Mishra B; Khan F
J Biomol Struct Dyn; 2019 Sep; 37(14):3822-3837. PubMed ID: 30261824
[TBL] [Abstract][Full Text] [Related]
4. Virtual screening, Docking, ADMET and System Pharmacology studies on Garcinia caged Xanthone derivatives for Anticancer activity.
Alam S; Khan F
Sci Rep; 2018 Apr; 8(1):5524. PubMed ID: 29615704
[TBL] [Abstract][Full Text] [Related]
5. 3D-QSAR studies on Maslinic acid analogs for Anticancer activity against Breast Cancer cell line MCF-7.
Alam S; Khan F
Sci Rep; 2017 Jul; 7(1):6019. PubMed ID: 28729623
[TBL] [Abstract][Full Text] [Related]
6. QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase IIα.
Alam S; Khan F
Drug Des Devel Ther; 2014; 8():183-95. PubMed ID: 24516330
[TBL] [Abstract][Full Text] [Related]
7. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents.
Azad I; Nasibullah M; Khan T; Hassan F; Akhter Y
J Mol Graph Model; 2018 May; 81():211-228. PubMed ID: 29609141
[TBL] [Abstract][Full Text] [Related]
8. In silico approaches to identify novel myeloid cell leukemia-1 (Mcl-1) inhibitors for treatment of cancer.
Ren JX; Li CP; Zhou XL; Cao XS; Xie Y
J Biomol Struct Dyn; 2018 Jul; 36(9):2424-2435. PubMed ID: 28714799
[TBL] [Abstract][Full Text] [Related]
9. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
[TBL] [Abstract][Full Text] [Related]
10. 2D- and 3D-QSAR modelling, molecular docking and
Shukla A; Tyagi R; Meena S; Datta D; Srivastava SK; Khan F
J Biomol Struct Dyn; 2020 Jan; 38(1):168-185. PubMed ID: 30686140
[TBL] [Abstract][Full Text] [Related]
11. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
Davis GD; Vasanthi AH
Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Molecular Docking, and 2D-QSAR Modeling of Quinoxaline Derivatives as Potent Anticancer Agents against Triple-negative Breast Cancer.
Kaushal T; Khan S; Fatima K; Luqman S; Khan F; Negi AS
Curr Top Med Chem; 2022; 22(10):855-867. PubMed ID: 35331094
[TBL] [Abstract][Full Text] [Related]
13. Computational Studies of bis-2-Oxoindoline Succinohydrazides and their In Vitro Cytotoxicity.
Jarapula R; Badavath VN; Rekulapally S; Manda S
Curr Comput Aided Drug Des; 2020; 16(3):270-280. PubMed ID: 30652647
[TBL] [Abstract][Full Text] [Related]
14. QSAR Study, Molecular Docking and Molecular Dynamic Simulation of Aurora Kinase Inhibitors Derived from Imidazo[4,5-
Tian YY; Tong JB; Liu Y; Tian Y
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675594
[TBL] [Abstract][Full Text] [Related]
15. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
[TBL] [Abstract][Full Text] [Related]
16.
Akabli T; Toufik H; Lamchouri F
J Biomol Struct Dyn; 2022 Jun; 40(9):3965-3978. PubMed ID: 33252029
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV.
Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
J Biomol Struct Dyn; 2019 Jan; 37(1):131-146. PubMed ID: 29268664
[TBL] [Abstract][Full Text] [Related]
18. Quantitative structure-activity relationship and molecular docking studies on human proteasome inhibitors for anticancer activity targeting NF-κB signaling pathway.
Yadav D; Mishra BN; Khan F
J Biomol Struct Dyn; 2020 Aug; 38(12):3621-3632. PubMed ID: 31514715
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, molecular properties and comparative docking and QSAR of new 2-(7-hydroxy-2-oxo-2H-chromen-4-yl)acetic acid derivatives as possible anticancer agents.
Elhenawy AA; Al-Harbi LM; El-Gazzar MA; Khowdiary MM; Moustfa A
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Jul; 218():248-262. PubMed ID: 31003050
[TBL] [Abstract][Full Text] [Related]
20. QSAR and docking based semi-synthesis and in vitro evaluation of 18 β-glycyrrhetinic acid derivatives against human lung cancer cell line A-549.
Yadav DK; Kalani K; Khan F; Srivastava SK
Med Chem; 2013 Dec; 9(8):1073-84. PubMed ID: 23675978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
